Humanity is a technology company.
Humanity has raised $3.0M across 1 funding round.
Humanity has raised $3.0M in total across 1 funding round.
Humanity has raised $3.0M in total across 1 funding round.
Humanity's investors include 7percent Ventures, Accomplice VC, Alpha Prime Fund, Molten Ventures, One Way Ventures, Charlie Songhurst, John Taysom, Rob Dobson, Air Street Capital, Arthur Kosten, Connect Ventures, David Rosenberg.
Humanity (humanity.health) is a UK-based consumer technology company developing a mobile app that tracks users' biological aging through digital, blood, and genetic biomarkers to provide personalized lifestyle recommendations for extending health span.[4][8] It serves individuals seeking to slow aging and reduce disease risk, solving the problem of limited actionable insights into personal aging processes by leveraging machine learning (ML) and AI models trained on biomedical data.[4][8] The app enables users to monitor their rate of aging and take targeted actions, positioning it in the growing longevity and preventive health tech market; while specific growth metrics are unavailable, its partnership with Neurons Lab for AI-enhanced datasets indicates scaling efforts amid data scarcity challenges.[4]
Humanity emerged from a mission to extend human health span using technology, founded as a consumer subscription service focused on biomarker tracking and AI-driven insights.[4][8] Specific founder details and exact founding year are not publicly detailed in available sources, but the company is UK-based and gained traction through innovative use of ML/AI to analyze user data for biological age determination and recommendations.[4] A pivotal moment was its partnership with Neurons Lab to augment limited real-user biomedical datasets with generative AI, addressing restrictions on personal data usage and enabling robust model training for scalable personalization.[4] This collaboration highlights early momentum in overcoming data hurdles central to its idea.
Humanity rides the longevity tech wave, fueled by advances in AI, genomics, and wearables that democratize anti-aging interventions amid rising demand for preventive health post-pandemic.[4][8] Timing aligns with market forces like aging populations, biomarker accessibility via consumer devices, and AI's ability to process vast health data—despite regulatory hurdles on personal datasets, which Humanity navigates through synthetic generation.[4] It influences the ecosystem by advancing AI applications in biomedicine, inspiring similar tools in personalized health while contributing to ethical data use in consumer AI, potentially accelerating mainstream adoption of health span optimization.
Humanity is poised to expand with enhanced AI models from generative data partnerships, targeting broader biomarker integration and global user growth in the booming $100B+ longevity market.[4] Trends like multimodal AI (combining wearables, blood tests, genetics) and regulatory support for health AI will shape its path, potentially evolving into ecosystem partnerships with pharma or insurers for validated outcomes. Its influence may grow by setting standards for accessible aging tech, empowering users to proactively extend health spans—reinforcing its core promise that technology can make staying healthy longer achievable for all.[8]
Humanity has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2020 | $3.0M Seed | 7percent Ventures, Accomplice VC, Alpha Prime Fund, Molten Ventures, One Way Ventures, Charlie Songhurst, John Taysom, Rob Dobson, Air Street Capital, Arthur Kosten, Connect Ventures, David Rosenberg, Hyper, Janis Krums, Märt Kelder, mExpand Family Office, Othman Laraki, Tony Jamous, Vinay Hiremath |